Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer [NA]

View source ↗

Summary

A terminated clinical trial evaluating stereotactic body radiation therapy for high-risk locally advanced head and neck cancers; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma
• Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
• Nasopharyngeal Squamous Cell Carcinoma
• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | NA | Status: TERMINATED | Results posted: 2018-11-16